SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " life science " 366 found 🔀 AI-powered Shuffle
5 things to know in life sciences: Week of Oct. 5, 2026
Each week we highlight five things affecting the life sciences industry. Here’s the latest.
Life Science Legal Strategy Summit 2026
Partner Bart Jong and associate Jasmeen Bahous will attend the Life Science Legal Strategy Summit 2026, taking place 13–14 October in Frankfurt. The event will bring together legal professionals and industry leaders to explore key legal, regulatory, and strategic developments shaping the life sciences sector.
Teradata Highlights New Enterprise AI Customer Engagements Across Healthcare & Life Sciences
Enterprise AI customer engagements show how healthcare and life sciences organizations are activating intelligence from their data and institutional knowledge at scale SAN DIEGO, Oct. 8, 2026 — Teradata has showcased three customer engagements that demonstrate how leading healthcare and life sciences organizations are closing the gap between institutional knowledge and real-world outcomes, advancing disease […]
European Commission allocates €65 million to protect life science data
The European Commission announced the €65 million funding on 6 October 2026 through Horizon Europe
All Roads Lead to Texas: 15th Annual Texas Life Science Forum to Bring Together Biotech’s Builders and Backers on Nov. 10 in Houston
The Rice Alliance for Technology and Entrepreneurship and BioHouston today announced that the 15th Annual Texas Life Science Forum is set for Tuesday, Nov. 1...
GenScript Launches Life Sciences Startup PitchFest with NVIDIA to Accelerate Biotech Innovation
/PRNewswire/ -- GenScript Biotech Corporation today announced the GenScript and NVIDIA Life Sciences Startup PitchFest, a global competition for startups...
IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today at TechIQ 2026 introduced IQVIA Life Science ModelsTM to help predict clinica
IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Oct 7, 2026--
IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Oct 7, 2026--
IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes
RESEARCH TRIANGLE PARK, N.C., October 07, 2026--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today at TechIQ 2026 introduced IQVIA Life Science ModelsTM to help predict clinical trial outcomes.
New AI trade group launches with focus on health sector
A new trade group launched this week to give artificial intelligence companies in the health, human services and life sciences worlds a collective voice in anticipation of state government writing …
Getinge Life Science president is leaving
Swedish medtech company Getinge announced today that the president of its Life Science business is resigning to pursue an external opportunity.
Dealroom.co | IIPR launches Series B preferred stock sale to fund life science loan
What's the deal? Innovative Industrial Properties (NYSE: IIPR),…
Life sciences firm Danaher to launch AI-powered autonomous research lab in 2027
Oct 7 (Reuters) - Life sciences company Danaher said on Wednesday it plans to launch its first AI-powered autonomous research lab early next year to make drug discovery and development faster and more efficient.
Life sciences firm Danaher to launch AI-powered autonomous research lab in 2027
Life sciences company Danaher said on Wednesday it plans to launch its first AI-powered autonomous research lab early next year to make drug discovery and development faster and more efficient.
New Report: 400+ Global Life Science Leaders Bullish Despite Market Uncertainty
As AI usage takes shape and market pressures persist, CRB's Horizons: Life Sciences 2026 report explores how manufacturers are investing in facilities,...
News | Populate hires director of science and innovation for £1 billion London Cancer Hub project
Angela Kukula was chief executive of life sciences cluster organisation MedCity
Will R.I. voters, elected officials continue investing in life sciences?
Rhode Island starts in a strong position and has the ingredients needed for innovation and growth. What we don’t have yet is a long-term commitment, writes the CEO of the RI Life Science Hub.
Cambridge and London Life Sciences Showcase returns during JPM Healthcare Week 2027
o2h co-discovery has announced that the Cambridge × London Life Sciences Showcase will return for its second edition during J.P. Morgan Healthcare Week 2027 in San Francisco.
Science Highlights Six Overlooked Pioneers Who Missed the Nobel Prize in Medicine
The international journal Science has spotlighted six groundbreaking achievements in the life sciences that never received Nobel Prize recognition.…
People on the Move: Andy Fenny Named President of Pace Life Sciences
Pace Life Sciences, the life sciences division of science and technology company Pace, has named Andrew (Andy) Fenny as its President. “Pace Life Sciences has…
BioHealth Capital Region - Regional Life Sciences Roundup - October 2, 2026
Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising…
East Bay tech and life science hub is bought by New York City investors
Price for property is far below its assessed value and loan.
East Bay tech and life science hub is bought by New York City investors
Price for property is far below its assessed value and loan.
IQHQ Lands $245M for Boston Life Science Campus
The first part of funding enabled the developer to pay off an existing bridge loan.
Four Life Science Startups Compete for the BioTools Innovator 2026 Award
After participating in BioTools Innovator’s four-month accelerator program, these finalists will contest on stage for a $250,000 prize during a capstone pitch event.
90% of Life Sciences Manufacturers Say Digital Transformation Is Now Business-Critical, According to New Rockwell Automation Report
/PRNewswire/ -- Rockwell Automation, Inc. (NYSE: ROK), the global leader in industrial automation and digital transformation, today released "The New Operating...
90% of Life Sciences Manufacturers Say Digital Transformation Is Now Business-Critical, According to New Rockwell Automation Report
/PRNewswire/ -- Rockwell Automation, Inc. (NYSE: ROK), the global leader in industrial automation and digital transformation, today released "The New Operating...
Innovative Industrial Properties Commits $245 Million to Cambridge Life Science Campus
Innovative Industrial Properties has committed $245 million in mezzanine financing for Alewife Park, a 27-acre life science campus in Cambridge,... Read More
Greater Philadelphia - Regional Life Sciences Roundup - October 1, 2026
Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising…
Xtalks Announces its Life Science Webinar Calendar for October 2026
Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field!
Xtalks Announces its Life Science Webinar Calendar for October 2026
/PRNewswire/ -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries....
Pasadena Life Science Incubator Reports “Transformational” Gift: Lab Building
Daily Newsmagazine and City Guide to Pasadena, California featuring local news, breaking news, events, weather, sports news, schools news, shopping, restaurants and more from Pasadena Now
September Monthly Review: Health MCP Guy?
For all the time I spend talking about APIs and data exchange, this newsletter has had embarrassingly little interoperability of its own. It’s old-school SaaS, baby - UI or bust. Not all of that is my fault! Substack, for all its popularity, is (as mentioned before) really frustrating as my system of record. The primary user it optimizes towards is the reader, whose attention feeds the app, the Notes feed, and the recommendation network that Substack is actually selling. Health API Guy is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe They’re falling into the same trap that Medium once sprinted into, albeit at a much more glacial speed. Younger generations may not remember (or never knew) it, but Medium once lured publications like The Ringer and Signal v. Noise onto its platform, only to lose them as it rebuilt itself around a paywall and an algorithmic feed. Substack’s original pitch circa 2020 was the antidote (you own your list), but every new feed feature chips away at it. I get it: writers are generic supply in the eyes of the Substack product team. Generic supply follows demand, so the consistent pressure on the PMs is to generate demand, which leads to every product cycle going toward discovery (Notes, recommendations, the app, live video). The end result lackluster author tools (laggy and broken analytics are truly crippling) all despite the premium price point. The archive is where it crosses from authorial gripes to actual reader impact, though. Across Substack and LinkedIn, I’ve published 1,218 posts and nearly 900,000 words since 2018. Substack’s native search can see only the 464 posts that live on Substack, and even there it’s woefully inadequate at surfacing relevant content (even for the guy who wrote it)! Readers have the same problem, writ large. Ask the Archive Fixing search (for both my readers and my own use) turned out to be extremely non-trivial, unfortunately: There’s no public API for readers to access content RSS exists for new content notification, but it only carries the 20 most recent posts and cuts paid ones off at the preview The only Substack MCP is an admin tool for analytics The export exists for authors, but it’s painfully awkward and slow. So I built something to work around that: the Health API Guy MCP. It’s a private MCP server holding the full text of everything I’ve written across Substack and LinkedIn. Add it to Claude or ChatGPT as a connector and you can ask things like: It pairs keyword search (for acronyms and case names, of which we have many) with semantic search. Every post is also labeled by topic, form, and court case, so you can pull a lawsuit’s (or multiple cases’) entire docket across Substack and LinkedIn in one query: Hail, Healthapiguyhydra This is also a bit of me eating my own cooking. I’ve spent the year arguing that headless healthcare is arriving and that developers want primitives over abstractions. Last week in Hail, Benihydra, I watched Salesforce plug its platform into Claude and bet that the records underneath outlive whatever interface sits on top: Salesforce must believe that the Hydra’s immortal head is the records, permissions, and business logic (in that they will survive whatever happens to the interface). It felt a bit hypocritical to keep my own archive behind a Substack search bar. The archive is the body. Substack is one head, and now whatever tool you might use is another. Will the EHRs follow my lead? Probably not imminently, but one can hope! Why Founding Members Only The MCP is available to Founding Member subscribers. A few reasons: It costs money and time to run. Hosting, the database, Clerk usage and AI compute for search and labeling are significant operational costs (that increase with usage). Substack gives me no way to automate access. There’s no API to check whether someone is a paid subscriber, so every user is manual operations for now. It’s a beta. We’ll need to improve things and parts will break. I’d rather they break for a small group of dedicated readers who will tell me about it. The Founding tier deserved a real benefit. Until now it was mostly a generous tip. Now it comes with something. If you’re already a Founding Member, reply to this email with the address you’d like provisioned. If you’re not and want in, upgrade here. Larger teams (such as companies) can get access too: group subscriptions at the Founding tier come with the group discount. The admin for the subscription can reply with the list of addresses to provision. Get 20% off a group subscription Pricing Founding membership is now a flat $200 a year, replacing the old suggested $150 that readers could adjust. Existing Founding Members will have access grandfathered in at their previous rate. Month in Review Articles Published Make Networks Dumb Again (Sep 11): AI is making old analog networks cheaper to use and flooding them with machine traffic in the process. A plea for agent-native rails with the intelligence at the endpoints, and for Washington to drag them to ubiquity. Interoperability, Unbuttoned (Sep 29): Interoperability is a series of workflows in a trenchcoat, and this post finally takes the trenchcoat off. A color-coded map shows which provider workflows went digital, which are fragmented, and which still run on fax. Video Content Antitrust’s System of Record Problem (Sep 3): The FTC’s investigation into Epic prompted a ninety-minute webinar, now posted with chapters and a smoothed transcript. We get into why market definition, missing B2B share data, and the SSNIP test leave antitrust poorly suited to systems of record, plus why information blocking may be doing more than any pending lawsuit. The Information Exchange: Cerner Milking Edition (Sep 18): This was so fucking fun. Ryan Tucker, Ryan Brickner, Brad Thorson, and I try an Around the Horn format, complete with points, penalties, and a mute button. We debate whether Oracle Health is dead, who would actually buy Cerner (IBM enters the chat), p(Doom), and why the front desk still hands you a clipboard. Regulatory Ask Not What Your Network Can Do (Sep 23): CDC’s RFI on public health data intermediaries lists use cases already served, unevenly, by eCR, lab reporting, IZ Gateway, and syndromic surveillance. The real opportunity sits in one question about AI: a network that can handle the next emergency without another interface project. Court cases Particle v. Epic: The Naughty Schoolteacher (Sep 4): After a summer-long vigil, the answer on Epic’s early summary judgment bid is two paragraphs and a remedial assignment. Particle advances to the next grade, and market definition gets another year of discovery. The Epic Discovery Files (Sep 8): Texas’s motions to compel arrive with a 251-page appendix of requests, objections, and meet-and-confer letters with Cravath. Inside: Epic using generative AI for document review, denied interoperability requests in scope, and Noerr-Pennington raised against lobbying discovery. Epic v. Health Gorilla: “Working as Designed” (Sep 9): Epic wants nothing to do with the data breach MDL, and explaining why puts fresh discovery on the public docket. The spiciest allegation: Health Gorilla told GuardDog to scrub its law firm business from its website instead of cutting off access. Veeva v. Epic: Legal Bypass Surgery (Sep 15): Veeva asks the Wisconsin Supreme Court to skip the Court of Appeals, while law professors and three policy groups line up as amici. Meanwhile, Epic’s lawyers apologize for another round of citation errors, including a quote that never existed. Texas v. Epic: Behind the Black Bars (Sep 17): The court portal served up Epic’s unredacted filings, revealing a $5 million document review budget and the AI workflow behind it. Also inside: the 200-plus company names Texas wants searched, and one very expensive Zoom invitation. OpenEvidence v. Doximity: Consequences Will Follow (Sep 25): OpenEvidence tells the court it will not comply with a discovery order, and its own lawyers at Quinn Emanuel say they won’t defend the choice. Add years of Slack reported unrecoverable, and Rule 37 sanctions come into view. Health Tech Keeps Choosing Violence (Sep 28): Doximity moves to end OpenEvidence’s case, Epic asks Texas to show its work, and a sleepy Audacious Inquiry patent fight sprouts antitrust and information blocking counterclaims. The main event is a long-sealed Cognizant v. Infosys ruling that hints where system of record antitrust claims can survive. EHRs One Verb for Oracle Health (Sep 14): Oracle’s earnings call quantifies every data center to the decimal point, while Oracle Health gets a single verb: “accelerate.” Panning the few healthcare mentions turns up an agentic care management system, a research-to-care ledger play, and the question of whether healthcare gets Larry’s patience. Epic’s Forretress Under Siege (Sep 30): Judy Faulkner tells a panel Epic paused hundreds of projects to harden its software and calls it a “shame,” while a spokesperson insists the roadmap hasn’t changed. Project Glasswing, a Pokémon-branded QAN sprint, and a trove of Jodel grievances reconcile the two Epics and preview the Jevons paradox coming for all software. Industry Analysis Scanning for a Network (Sep 1): Scan.com raises $220M to build the imaging network labs never got, speedrunning Zocdoc’s consumer-to-B2B pivot. Its wedge to network density may be the most American one available: personal injury litigation. The Front Desk Wants the Damn Whole Building (Sep 16): Hello Patient buys Converse Health, pushing its AI front desk into referrals, chart work, and prior auth. The copilot categories keep blurring, and your distribution partner is still your final boss. Cross-industry Comparisons A Different Patchwork Quilt (Sep 10): Healthcare loves to envy open banking, but the US version has no mandate, a toll booth at Chase, and data quality problems of its own. The grass isn’t greener; it’s another American patchwork quilt, and perhaps a worse one. Hail, Benihydra (Sep 21): Salesforce brings its platform into Claude, Slack, and its own agent, inviting the interfaces that might replace it. Cut off one head and more grow back, so long as the records underneath stay put. Living on A Trade Secret Prayer (Sep 22): Six credit unions are suing Fiserv, the Epic of core banking, by claiming their own member records as trade secrets. Banking has no Cures Act, so its lawyers reach for legal alchemy that healthcare has already tried. Other News None this month External Media Nabla Accelerate NYC: I kicked off fall conference season at Nabla’s Accelerate event in New York, where Delphine Groll opened by asking the room to picture the company it wants to become and the one it doesn’t. I liked her framework of bureaucracy, fear, and ego as the blockers. I also love vendor conferences/events in general - different vibe than industry biggies. Healthcare 101 with Nikhil Krishnan: I briefly guest lectured Out-Of-Pocket’s Healthcare 101 class. Appreciated Nikhil’s takeaways cover whether AI doctors can query HIEs, why healthcare’s data-liberation rules beat most industries’, and the hi-res graphic is in the comments. HCN: Epic Probed by the FTC: I joined the HCN guys to talk through the FTC’s investigation into Epic. Cedric’s new hairdo was an unexpected plot twist. The episode also covers MFN drug pricing, healthcare M&A and Eli Lilly’s acquisition streak. Fall Conferences: At eHealth Exchange’s Annual Meeting in Austin on Oct 27, I’ll moderate a panel on the tensions between AI, HIEs, and timely patient access with Jean Ross (Primary Record), Therasa Bell (Kno2), Byron Crowe (Doctronic), and Michael Marchant (Freenome). Here’s the rest of my schedule if you want to meet up: CommonWell (Redwood Shores, CA): Oct 13-14 Will be participating in a fun Jeopardy event Open@Epic (Madison, WI): Oct 20-23 Will be enjoying Verona, Willy Street, and other local adventures eHealth Exchange and Sequoia Project (Austin, TX): Oct 27-29 Yeehaw HLTH (Vegas): Nov 15-18 Groundhog Day, Venetian Edition RSNA (Chicago): Nov 30-Dec 2 See me at “Governing AI in Breast Imaging: What Health Systems Are Actually Doing” Digital Health Counsel 2026 AI Summit (Seattle): December 2-3 Will likely be speaking to a bunch of lawyers about information blocking Posts I Liked ChatGPT’s Epic integration: game changer or nothing burger?: Joshua Liu, MD offers five thoughts on OpenAI’s Epic launch, starting from the point that it rides the same open APIs available to anyone. He argues read-only access leaves ordering to Art and the ambient startups, and asks why HCA is piloting it alongside Commure. He’s sorta a must-follow at this point - consistently excellent, thought-provoking takes. Epic, Lilly, and the Discovery pass: Seth Chaney reads Epic’s first major Discovery deal (with Eli Lilly), as well as its revised developer terms on commercial displays, as the pipe finally opening between EHRs and pharma. Life sciences and health continue to collide. Scott Rossignol on EHR payer platforms and ePA fees: Scott argues the top ambulatory EHR vendors are turning the prior auth mandate into a per-member-per-year toll on payers, for an API whose operating cost has nothing to do with covered lives. His fix is two lines of regulatory text: put the CRD/DTR/PAS certification criteria in the Base EHR definition, and bring payer-facing ePA connectivity under § 170.404’s cost-based fee rules. It’s a good solution. Health API Guy is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe
BioMed to Land $915M for Life Science Asset
BioMed will soon secure a $915 million mortgage loan for 585 Kendall, a life science property in Cambridge, Mass.
OBIO marks $1bn funding milestone for Canadian health tech ventures
Life sciences and technology companies supported by the OBIO's CAAP have collectively raised more than $1bn in capital.
Domino Data Lab and EPAM Partner to Accelerate AI Adoption in Life Sciences
Combines Domino’s enterprise platform with EPAM’s global engineering to scale compliant AI applications and advanced analytics across global biopharma SAN FRANCISCO, Sept. 29, 2026 — Domino Data Lab, provider of the unified platform to build, scale, and govern enterprise AI solutions for the most consequential industries, today announced a strategic partnership with EPAM, a leading […]
Caris Life Sciences Unveils the Next Evolution of Liquid Biopsy with Enhanced Caris Assure
/PRNewswire/ -- Caris Life Sciences® (Caris), a leading AI TechBio company, today unveiled the enhanced Caris Assure®, a new evolution of liquid biopsy. By...
Healey awards $40M in tax incentives to life science company, expected to create 1,600 jobs
Nearly $40 million in tax incentives went out to 38 life science companies in Massachusetts, a move state leaders say is expected to create over 1,600 jobs in the industry.
Dominique Lewis, Spotlighted By Influential Women, Connects Life Science Expertise With Holistic Wellness
A Career Rooted in Scientific Knowledge, Personal Growth, and Meaningful Transformation Washington, DC – Dominique Lewis has developed a distinctive
BioHealth Capital Region - Regional Life Sciences Roundup - September 25, 2026
Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising…
What moving to a healthcare AI reality looks like for Oracle
Supporting care pathways and clinical workflows with new artificial intelligence agents is not a bid to replace providers, say Oracle leaders as they detail the company's progress integrating AI at the annual 2026 Oracle Health and Life Sciences Summit.
Oracle Adds Domain-Trained AI to Life Sciences Data Intelligence Platform
Natural-language, domain-aware AI capabilities and expanded analytics tools enable pharmaceutical research teams to explore real-world data and generate traceable, decision-ready evidence ORLANDO, Fla., Sept. 24, 2026 — Oracle Life Sciences Data Intelligence now combines real-world data, domain-trained AI capabilities, and advanced analytics in a single connected intelligence platform, helping pharmaceutical research teams move from questions […]
Oracle Health and ID.me Team to Simplify Secure Access to Health Data
/PRNewswire/ -- Oracle Health and Life Sciences Summit – Oracle Health and ID.me today announced a collaboration to integrate ID.me's trusted digital identity...
Oracle Health rolls out AI solutions for RCM, oncology as part of broader healthcare, life sciences strategy
ORLANDO, Fla.—Healthcare is entering an AI era, and the industry needs a fundamentally different architecture designed for AI from the start, Oracle Health executives said Wednesday. | Healthcare is entering an AI era, and the industry needs a fundamentally different architecture designed for AI from the start, Oracle Health executives said Wednesday.
Orange Boosts Life Science Portfolio With Biolevate Funding
Claire Scotton, VP Healthcare & Life Sciences at Orange, explains that Biolevate can accelerate life sciences innovation with trusted AI and workflows
life – the bioRN Life Science Cluster magazine
Alliances for success – Heidelberg and the Rhine-Neckar region are among the most dynamic life science ecosystems in Europe.
Oracle and Buck Institute for Research on Aging Advance Federal Aging Research Initiative
ORLANDO, Fla., Sept. 23, 2026 — Oracle Health and Life Sciences Summit — Oracle and the Buck Institute for Research on Aging are collaborating to advance intelligence into age-related disease and support discoveries that can extend the healthy years of life. Buck will leverage Oracle Life Sciences Data Intelligence, which encompasses 122 million+ de-identified longitudinal […]
Genialis and Inventia Life Science Collaborate to Link Patient Biology with 3D Pancreatic Cancer Models
Recent advances in targeted therapies for pancreatic cancer have brought renewed attention to the Pancreatic Cancer Action Network.
Genialis and Inventia Life Science Collaborate to Link Patient Biology with 3D Pancreatic Cancer Models
HOUSTON & SYDNEY, September 23, 2026--The Genialis Supermodel and Inventia's RASTRUM 3D cell model platform together will build models of PDAC that better represent tumor biology.
Merck Life Science Expands Bengaluru Manufacturing with €13 Million Investment
Merck Life Science is expanding its manufacturing capabilities in Bengaluru with an investment of approximately €13 million, strengthening the company’s ability to supply critical materials to customers across India and the wider Asia-Pacific region. The expansion at Merck Life Science’s Jigani site in Bengaluru will introduce biological buffer manufacturing alongside the facility’s established chemistry capabilities. The investment is designed to enable faster and more reliable access to critical materials used by customers across research, diagnostics, biotechnology and biopharmaceutical manufacturing. The development further advances Merck Life Science’s “in-region, for-region” approach, under which the company is expanding manufacturing capabilities closer to the markets and customers it serves. By adding biological buffer production in India, the Jigani expansion will broaden the site’s manufacturing capabilities while strengthening Merck Life Science’s regional supply infrastructure for the rapidly developing life sciences sector across India and Asia-Pacific. The company said the expansion reflects both the contribution of its teams and its collaboration with government and industry stakeholders. Merck Life Science acknowledged the support of India’s Department for Promotion of Industry and Internal Trade (DPIIT), the German Embassy New Delhi, and Invest India in helping strengthen life science manufacturing capabilities in the region. The investment comes as India continues to expand its role across pharmaceutical, biotechnology, diagnostics and biomanufacturing value chains, increasing demand for dependable regional access to materials supporting research and manufacturing operations. The Bengaluru expansion reinforces Merck Life Science’s focus on building manufacturing capacity within Asia-Pacific and supporting customers through a more regionalised supply network.
2026 CALS Distinguished and Outstanding Alumni Honored
The College of Agriculture and Life Sciences celebrated its alumni award winners on Sept. 18. From the field to the lab, find out how they're making an impact.
Wave Life Sciences Appoints Monika Vnuk as Chief Business Officer
Wave Life Sciences appoints Monika Vnuk, MD, as Chief Business Officer to lead business and corporate development efforts.Quiver AI SummaryWave Life Sciences Ltd. announced the appointment of Dr. Monika Vnuk as Chief Business Officer, bringing extensive experience from her previous roles at Sanofi, Blackstone, and Pfizer. In her new role, Dr. Vnuk will oversee business and corporate development, as well as alliance management, aimed at advancing
“Nurturing tomorrow’s Einsteins in Dalseong-gun”: DGIST Science Creativity School opens admissions for the 2027 academic year
- Advanced education in four fields—mathematics, physics, chemistry, and life science—with full tuition support for sixth-grade elementary and first-year middle school students in Dalseong-gun - “Taught Directly by DGIST Faculty”: Customized advanced education for gifted students in the region
Scientists Report Continuing Harms to U.S. Science in Second-Year Survey
A survey of scientists across a variety of life sciences details how federal government policies have created ongoing disruptions to American research and the scientific workforce.
Anthropic Eases AI Safeguards for Verified Life Science Teams
Sept. 21, 2026 — Anthropic has introduced the Life Sciences Verification Program (LSVP), which gives life science professionals access to Mythos, Opus, and Sonnet models with a refined set of safeguards more permissive for biology-related work. Dozens of organizations have already been onboarded through an early-access program, and applications are now open to the broader life […]
‘Enormous potential’: UK envoy seeks deeper Israel ties in science, technology and trade
Ambassador Simon Walters tours the Oxford-Cambridge Growth Corridor, meeting researchers, investors and industry leaders as Britain seeks new partnerships with Israel in genomics, life sciences, agri-tech, AI and clean tech despite political differences
NC State Alumnus Establishes Full Scholarship for Undergraduate Students in Agriculture Majors
A $10 million gift from NC State alumnus David Peele will give students from eastern North Carolina the opportunity to attend NC State’s College of Agriculture and Life Sciences with the full cost of attendance covered – and spend four years immersed in the research, mentorship and experiences preparing them to lead the future of agriculture.
Science program elimination at Southeastern Voc Tech sparks backlash
Natural life sciences students and alumni crowded a September school board meeting to passionately defend the value of the shop.
Anthropic Sets Up Wet Lab In San Francisco Bay Area For AI Life Sciences Work
Gizmodo pitches the wet lab as drug development, while Engadget emphasises Anthropic said it was not created for drug discovery.
Four new life sciences departments showcase USC Dornsife’s strengths in biology
USC Dornsife has given four longstanding fields clearer academic identities, increasing their visibility in research and graduate education.
5 things to know in life sciences: Week of Sept. 14, 2026
FDA launches pilot to accelerate early-stage drug development. This and more in this week’s life sciences update.
Google Moving Into Former Science Lab Space in Watertown
A life science lab project permitted to be built at the Arsenal on the Charles complex has a tenant listed as “Google.” It is not clear what the tech giant plans to do with the space, according to the report by Watertown’s Sam Ghilardi. The space is located at 200 Talcott Ave. formerly housed Werewolf […]
Life Sciences Building Debuts Despite Donor Controversy
Seven years after its conception, the Casper Life Sciences Building had its official debut on Tuesday, Sept. 8, giving students access to 197,300 square feet of labs, classrooms, and study spaces on a $250 million budget. The building will replace Hall-Atwater, previous home to biology and chemistry labs, which is set to be demolished in […]
Acore takes control of Beacon Capital’s Hell’s Kitchen life science development
Acore Capital has put an end to Beacon Capital Partners’ plans to build a life science development in Hell’s Kitchen. The lender took control of two office buildings at 707 11th Avenue and 615 West 50th Street that were once used as Kenneth Cole’s headquarters and more recently pegged for a 185,000-square-foot life science development. The sale was a deed-in-lieu of foreclosure, according to property records. The transfer value of the sale was $60 million, per records. PincusCo first reported the news. Beacon Capital Partners and CalSTRS partnered with Georgetown to buy the properties from SL Green for $95 million […]
From Science to Signals, Part II: What the SEC-FDA Cooperation Agreement Means for Life Sciences Companies
The SEC and FDA have formalized an emerging enforcement trend. We recently described the SEC’s evolving approach to insider trading,...
BioTech Social Announces Advisory Board To Advance Financial Innovation For Life Science Companies
× This page requires Javascript. Javascript is required for you to be able to read premium content. Please enable it in your browser settings. kAm k^Am kAm k^AmkAm k^AmkAm k^AmkAm k^AmkAmk6>mtIA6C:6?465 =6256CD 24C@DD 3:@E649?@=@8J[ 7:?2?46[ E649?@=@8J[ A2E:6?E 6?8286>6?E[ 4@>>F?:42E:@?D[ 2?5 4@>A2?J 3F:=5:?8 H:== 25G:D6 q$x 2D :E 3F:=5D 7:?2?4:2= :?7C2DECF4EFC6 2C@F?5 =:76 D4:6?46 :??@G2E:@?k^6>mk^AmkAmqt%wt$sp[ |5][ $6AE6>36C `f[ a_ae \ , k2 9C67lQ9EEAi^^^?6HDC@@>^Q C6=lQ?@@A6?6CQmz~#t(x#tk^2m . q:@%649 $@4:2= x?4] Wq$xX[ A2C6?E 4@>A2?J @7 q:@%649 uF?5:?8 !@CE2=[ E@52J 2??@F?465 E96 7@C>2E:@? @7 2? 25G:D@CJ 3@2C5 3C:?8:?8 E@86E96C 6IA6C:6?465 =6256CD 7C@> 3:@E649?@=@8J[ 962=E942C6[ 7:?2?46[ E649?@=@8J[ A2E:6?E 25G@424J[ 4@>>F?:42E:@?D[ 2?5 4@>A2?J 3F:=5:?8]k^AmkAm%96 25G:D@CJ 3@2C5 H:== DFAA@CE q$x’D 3C@256C >:DD:@? @7 255C6DD:?8 @?6 @7 E96 >@DE A6CD:DE6?E 492==6?86D :? =:76 D4:6?46Di 4@??64E:?8 AC@>:D:?8 :??@G2E:@? H:E9 E96 42A:E2= ?66565 E@ 25G2?46 E9C@F89 =6?8E9J 2?5 6IA6?D:G6 56G6=@A>6?E A2E9H2JD]k^AmkAmq$x :D 3F:=5:?8 7:?2?4:2= :?7C2DECF4EFC6 2C@F?5 =:76 D4:6?46 :??@G2E:@?] q:@%649 uF?5:?8 !@CE2=[ :ED $tr\C68:DE6C65 2?5 ux}#p\>6>36C #68F=2E:@? rC@H57F?5:?8 A@CE2=[ C6AC6D6?ED E96 4@>A2?J’D 7:CDE :>A=6>6?E2E:@? @7 E92E DEC2E68J] ~G6C E:>6[ q$x :?E6?5D E@ 6IA=@C6 255:E:@?2= 7:?2?4:2= DECF4EFC6D[ E@@=D[ 2?5 G69:4=6D 56D:8?65 2C@F?5 E96 5:DE:?4E:G6 42A:E2= ?665D @7 =:76 D4:6?46 4@>A2?:6D]k^AmkAm“$4:6?E:DED DA6?5 J62CD 56G6=@A:?8 D@=FE:@?D 7@C 5:D62D6D 7@C H9:49 A2E:6?ED DE:== 92G6 E@@ 76H @AE:@?D[ @?=J E@ D66 E96> 72:= 5F6 E@ 7F?5:?8 82AD 2E E96 EC2?D:E:@? :?E@ 4=:?:42= 56G6=@A>6?E” D2:5 sC] }6G2 (6DE[ rt~ 2?5 r@\u@F?56C @7 q$x] “p5G2?4:?8 E92E C6D62C49 C6BF:C6D DFDE2:?65 DFAA@CE @G6C >2?J J62CD] (6 H2?E E@ 96=A 4C62E6 2? 6?G:C@?>6?E :? H9:49 AC@>:D:?8 4=:?:42= D4:6?46[ >66E:?8 ECF6 F?>6E ?665D[ 42? 4@?E:?F6 >@G:?8 7@CH2C5 H9:=6 >F?:E:6D 27764E65 3J E96 5:D62D6 46?EC2= E@ E96 4@?G6CD2E:@?]”k^AmkAmp55C6DD:?8 E96 {:76 $4:6?46 “'2==6J @7 s62E9”k^AmkAm%96 7:?2?4:?8 492==6?86 :D A2CE:4F=2C=J 24FE6 5FC:?8 E96 D@\42==65 7F?5:?8 “G2==6J @7 562E9”[ E96 A6C:@5 :? H9:49 4@>A2?:6D >FDE 4@?E:?F6 :?G6DE:?8 :? C6D62C49[ 4=:?:42= 56G6=@A>6?E[ C68F=2E@CJ H@CA2?J 3F:=5:?8[ @7E6? 367@C6 E96J 42? 86?6C2E6 >62?:?87F= 4@>>6C4:2= C6G6?F6 @C 2EEC24E EC25:E:@?2= :?DE:EFE:@?2= 42A:E2=]k^AmkAmq$x =2F?4965 q:@%649 uF?5:?8 !@CE2= :? yF?6 a_ae 2D 2 C68F=2E65 :?G6DE>6?E 4C@H57F?5:?8 A@CE2= 3F:=E DA64:7:42==J 7@C =:76 D4:6?46 4@>A2?:6D] %96 A@CE2= 6?23=6D 6=:8:3=6 4@>A2?:6D E@ C2:D6 FA E@ Sd >:==:@? :? 42A:E2= 2??F2==J 7C@> :?5:G:5F2= :?G6DE@CD F?56C #68F=2E:@? rC@H57F?5:?8 H9:=6 4C62E:?8 @AA@CEF?:E:6D 7@C 2 3C@256C A@AF=2E:@? @7 :?G6DE@CD E@ A2CE:4:A2E6 :? AC:G2E6 =:76 D4:6?46 :??@G2E:@?]k^AmkAmq$x G:6HD E96 A@CE2= 2D E96 368:??:?8 @7 2 =2C86C 677@CE]k^AmkAm“q:@%649 uF?5:?8 !@CE2= :D @FC 7:CDE :>A=6>6?E2E:@?[ ?@E E96 6?5A@:?E[” D2:5 qC:2? !] r9C:DE:6[ r92:C 2?5 r@\u@F?56C @7 q:@%649 $@4:2= x?4] “~FC 3C@256C @3;64E:G6 :D E@ 3F:=5 7:?2?4:2= :?7C2DECF4EFC6 2C@F?5 E96 D4:6?46[ 56G6=@A:?8 7:?2?4:?8 >6492?:D>D E92E 36EE6C >2E49 42A:E2= E@ E96 >:=6DE@?6D[ C:D6?E]”k^AmkAmr9C:DE:6 25565[ “rC@DD:?8 E96 G2==6J @7 562E9 :D ?@E D:>A=J 2 7F?5C2:D:?8 AC@3=6>] %96 42A:E2= 92D E@ H@C< H:E9:? 2 >F49 =2C86C DJDE6> :?G@=G:?8 D4:6?E:7:4 >:=6DE@?6D[ C68F=2E@CJ A2E9H2JD[ A2E:6?ED[ DEC2E68:4 A2CE?6CD[ 4@>A2?J =6256CD9:A[ 2?5 :?G6DE@C 6IA64E2E:@?D] %92E :D @?6 C62D@? H6 H2?E65 2? 25G:D@CJ 3@2C5 H:E9 DF49 2 H:56 C2?86 @7 6IA6C:6?46]”k^AmkAmp |F=E:5:D4:A=:?2CJ p5G:D@CJ q@2C5k^AmkAm%96 25G:D@CJ 3@2C5 3C:?8D E@86E96C =6256CD H9@ 92G6 3F:=E 2?5 7:?2?465 4@>A2?:6D[ 56G6=@A65 3:@E649?@=@8J A2CE?6CD9:AD[ ?2G:82E65 C68F=2E65 >2CF?:E:6D[ >2?2865 4@CA@C2E6 C6AFE2E:@?[ 2?5 2DD6>3=65 =6256CD9:A E62>D]k^AmkAm%96 8C@FA :?4=F56D sC] x>25 p;;2H:[ q@3 q2C:49[ y@9? r@FC:4[ z2C:? w6==DG:6?6?4:2 ~CE:K[ (:==:2> $49C256C[ 2?5 p?5C6H (:==:D]k^AmkAmsC] x>25 p;;2H:[ p5G:D@C[ :D rt~ 2?5 r@\u@F?56C @7 #J3@sJ?[ 2 3:@E649?@=@8J 4@>A2?J 56G6=@A:?8 42?46C :>>F?@E96C2A:6D E2C86E:?8 2 4CJAE:4 AC@E6@>6] !C6G:@FD=J[ 96 H2D ':46 !C6D:56?E @7 qFD:?6DD s6G6=@A>6?E 2E p3D4:[ H96C6 96 5C@G6 >@C6 E92? Se__ >:==:@? :? A2CE?6CD9:AD 2?5 A=2J65 2 C@=6 :? E96 4@>A2?J’D S`]d 3:==:@? x!~] w6 2=D@ 4@\7@F?565 px\5C:G6? AC@E6:? 56D:8? 4@>A2?J s6?@G:F>[ H9:49 H2D 24BF:C65 3J p3D4:] p;;2H: 9@=5D 2 !9s :? q:@496>:DECJ 2?5 |@=64F=2C q:@=@8J 2?5 2? |qp 7C@> E96 #25J $49@@= @7 |2?286>6?E 2E &r $2? s:68@]k^AmkAmq@3 q2C:49[ p5G:D@C[ :D 2? 6I64FE:G6 D62C49 AC@76DD:@?2= H:E9 >@C6 E92? ae J62CD @7 6IA6C:6?46 C64CF:E:?8 4@>>F?:42E:@?D[ AF3=:4 C6=2E:@?D[ :?G6DE@C C6=2E:@?D 2?5 8@G6C?>6?E 2772:CD =6256CD] %9C@F89 r}# $62C49[ 96 H@C =6256CD9:A ?665D] w:D 6IA6C:6?46 DA2?D &]$] 2?5 :?E6C?2E:@?2= >2C246FE:42= 2?5 962=E942C6 4@>>F?:42E:@?D[ 4@?DF>6C AC@5F4ED 2?5 7:?2?4:2= D6CG:46D]k^AmkAmy@9? r@FC:4[ p5G:D@C[ 3C:?8D >@C6 E92? 7@FC 564256D @7 6IA6C:6?46 24C@DD 7:?2?46[ 32?@?E@CJ x?E6C7:?2?4:2= }6EH@C 7C@> :ED 62C=J J62CD E9C@F89 :ED 8C@HE9 :?E@ 2 7:?2?4:2= D6CG:46D ?6EH@C< DFAA@CE:?8 E9@FD2?5D @7 :?DE:EFE:@?D ?2E:@?H:56] t2C=:6C[ 96 96=5 =6256CD9:A A@D:E:@?D 2E !$x}6E 2?5 q6== pE=2?E:4[ ?@H '6C:K@? 2?5 AC6G:@FD=J H@C>:DD:@? W$trX] w6 9@=5D 2? |qp 7C@> %96 v6@C86 (2D9:?8E@? &?:G6CD:EJ 2?5 2 q$ :? r@>>6C46 7C@> E96 &?:G6CD:EJ @7 ':C8:?:2]k^AmkAmz2C:? w6==DG:D] (:==:D D6CG6D @? E96 w62=E942C6 2?5 !92C>246FE:42= |2?286>6?E !C@8C2> p5G:D@CJ q@2C5 2E r@=F>3:2 qFD:?6DD $49@@= 2?5 E96 q@2C5 @7 p5G:D@CD 2E v6@C86E@H? &?:G6CD:EJ’D |4s@?@F89 $49@@= @7 qFD:?6DD] w6 62C?65 2 q$qp 7C@> v6@C86E@H? &?:G6CD:EJ 2?5 2 ys 2?5 |qp 7C@> r@=F>3:2 &?:G6CD:EJ]k^AmkAmu:?2?4:2= |@56=D s6D:8?65 pC@F?5 w@H {:76 $4:6?46D s6G6=@Ak^AmkAm{:76 D4:6?46 4@>A2?:6D 5:776C 7F?52>6?E2==J 7C@> >2?J @E96C 6>6C8:?8 3FD:?6DD6D] r2A:E2= C6BF:C6>6?ED 2C6 7C6BF6?E=J 5C:G6? 3J D4:6?E:7:4[ 4=:?:42= 2?5 C68F=2E@CJ >:=6DE@?6D C2E96C E92? 4@?G6?E:@?2= C6G6?F6 8C@HE9] s6G6=@A>6?E E:>6=:?6D 42? DA2? J62CD[ 2?5 D:8?:7:42?E 6?E6CAC:D6 G2=F6 >2J 36 4C62E65 H6== 367@C6 2 AC@5F4E C62496D E96 >2C@56=D E92E >@C6 4=@D6=J C67=64E 9@H =:76 D4:6?46 :??@G2E:@? 24EF2==J AC@8C6DD6D]k^AmkAm“u@C >6[ E9:D F=E:>2E6=J 4@>6D 324< E@ D4:6?46 2?5 E96 A6@A=6 :E :D :?E6?565 E@ D6CG6[” (6DE D2:5] “!2E:6?ED 2?5 A2E:6?E 4@>>F?:E:6D @7E6? F?56CDE2?5 3@E9 E96 FC86?4J @7 F?>6E ?665 2?5 E96 C62=:E:6D @7 =:G:?8 H:E9 5:D62D6 :? H2JD E92E 42? 255 :>A@CE2?E A6CDA64E:G6 E@ E96 56G6=@A>6?E AC@46DD 2?5 E96J D9@F=5 36 23=6 E@ :?G6DE :? E96D6 4@>A2?:6D] pD H6 E9:?< 23@FE ?6H H2JD E@ DFAA@CE 6>6C8:?8 =:76 D4:6?46 4@>A2?:6D[ H6 H2?E E9@D6 A6CDA64E:G6D C6AC6D6?E65 2=@?8D:56 E9@D6 @7 D4:6?E:DED[ 6?EC6AC6?6FCD[ 2?5 :?G6DE@CD]”k^AmkAmq$x 6IA64ED E96 25G:D@CJ 3@2C5 E@ AC@G:56 DEC2E68:4 8F:52?46 2D E96 4@>A2?J 56G6=@AD q:@%649 uF?5:?8 !@CE2= 2?5 6G2=F2E6D 255:E:@?2= 2AAC@2496D E@ 6IA2?5:?8 2446DD E@ 42A:E2= 7@C =:76 D4:6?46 4@>A2?:6D]k^AmkAm“~FC 7@4FD :D DEC2:89E7@CH2C5[” r9C:DE:6 D2:5] “%96C6 :D C6>2C6C8:?8 4@>A2?:6D[ 2?5 E@@ >F49 @7 :E 6?4@F?E6CD 2 7:?2?4:?8 82A 367@C6 :ED A@E6?E:2= 42? 36 G2=:52E65] (6 H2?E E@ 3F:=5 7:?2?4:2= :?7C2DECF4EFC6 E92E 8:G6D >@C6 @7 E92E D4:6?46 2? @AA@CEF?:EJ E@ >2A2?J 56G6=@AD A=2E7@C>D[ E@@=D[ 2?5 7:?2?4:2= DECF4EFC6D :?E6?565 E@ 6IA2?5 2446DD E@ 42A:E2= 7@C 3:@E649?@=@8J[ A92C>246FE:42=[ >65:42= E649?@=@8J[ 5:28?@DE:4[ 5:8:E2= 962=E9[ 2?5 @E96C =:76 D4:6?46 4@>A2?:6D] q:@%649 $@4:2= x?4] :D E96 A2C6?E 4@>A2?J @7 q:@%649 uF?5:?8 !@CE2= {{r]k^AmkAmu@C >@C6 :?7@C>2E:@?[ G:D:Ei k2 9C67lQ9EEADi^^HHH]3:@E649]D@4:2=Qm9EEADi^^HHH]3:@E649]D@4:2=k^2mk^AmkAmp3@FE q:@%649 uF?5:?8 !@CE2=k^AmkAmq:@%649 uF?5:?8 !@CE2= :D 2? $tr\C68:DE6C65 7F?5:?8 A@CE2= 2?5 ux}#p >6>36C 7@4FD65 6I4=FD:G6=J @? =:76 D4:6?46 4@>A2?:6D C2:D:?8 42A:E2= F?56C #68F=2E:@? rC@H57F?5:?8] %96 A@CE2= 6?23=6D 6=:8:3=6 4@>A2?:6D E@ C2:D6 FA E@ Sd >:==:@? :? 42A:E2= 2??F2==J 7C@> :?5:G:5F2= :?G6DE@CD H9:=6 AC@G:5:?8 :?G6DE@CD 2446DD E@ AC:G2E6 =:76 D4:6?46 :?G6DE>6?E @AA@CEF?:E:6D F?56C #68F=2E:@? rC@H57F?5:?8]k^AmkAmx?G6DE>6?E @AA@CEF?:E:6D @776C65 E9C@F89 q:@%649 uF?5:?8 !@CE2= 2C6 DA64F=2E:G6[ :==:BF:5[ 2?5 :?G@=G6 2 9:89 568C66 @7 C:D6?E] %9:D AC6DD C6=62D6 :D 7@C :?7@C>2E:@?2= AFCA@D6D @?=J 2?5 5@6D ?@E 4@?DE:EFE6 2? @776C E@ D6== @C D@=:4:E2E:@? @7 2? @776C E@ 3FJ 2?J D64FC:EJ] p?J D64FC:E:6D @776C:?8 4@?5F4E65 E9C@F89 q:@%649 uF?5:?8 !@CE2= :D >256 @?=J AFCDF2?E E@ 2AA=:423=6 @776C:?8 >2E6C:2=D 7:=65 H:E9 E96 &]$] $64FC:E:6D 2?5 tI492?86 r@>>:DD:@?]k^AmkAmu@C >@C6 :?7@C>2E:@?[ G:D:Ei k2 9C67lQ9EEADi^^HHH]3:@E649]7F?5Qm9EEADi^^HHH]3:@E649]7F?5k^2mU?3DAjk^AmkAm|65:2 r@?E24Eik^AmkAm{66\p?? |FCA9Jk^AmkAmq:@%649 $@4:2= x?4k^AmkAmk2 9C67lQ>2:=E@i=662??o3:@E649]D@4:2=Qm=662??o3:@E649]D@4:2=k^2mU?3DAjk^AmkAm k^Am
When DNA sounds a lasting alarm: cGAS-STING links aging to brain inflammation
Neurodegenerative diseases, cerebrovascular disorders and other age-related neurological conditions are major causes of long-term disability. A review published in SCIENCE CHINA Life Sciences by researchers from Huashan Hospital, Fudan University, examines how damaged nuclear DNA and mitochondrial DNA can become immune danger signals. The authors highlight cGAS-STING as a key molecular hub linking cellular damage, inflammaging and neuroimmune dysfunction, and discuss opportunities for more precise therapeutic intervention.
Adora Life Science Announces the Appointment of Dr. Clinton D. Morgan as Chief Medical Officer
Adora Life Science (Adora) today announced that Dr. Clinton D. Morgan, MD, will be joining Adora as its full-time Chief Medical Officer, effective November 1, 2026. Dr. Morgan has previously been appointed to Adora's Board of Directors and has been consulting part-time on human therapeutic opportunities, mechanism of action and development strategies. Dr. Morgan will spearhead Adora's human clinical development, regulatory strategy, and the company's scientific and research network.
Beacon of discovery
Biomedical science Ph.D. student Lucy Williamson conducts cancer cell research in a Whitley H35 Hypoxystation, which creates hypoxic conditions within a controlled and sustained workstation environment in the Mugar Life Sciences building.
Deal Trends
Our partners share insights on the trends shaping dealmaking in the Life Sciences sector—and what to watch in the months ahead.
Polsky 10: UtilityInnovation Group acquired for projected $2.6B | Aura Life Science joins ISS accelerator | OrisDX launches first diagnostic product - Polsky Center for Entrepreneurship and Innovation
The Polsky 10 is a bi-weekly newsletter featuring 10 things to know from the University of Chicago’s Polsky Center.
PulsePoint Extends Exclusive Programmatic EHR Partnership with Flora Health Advancing In-Workflow Activation for Life Sciences Brands
/PRNewswire/ -- PulsePoint, the leading technology company transforming healthcare marketing, today announced an extension of its exclusive programmatic EHR...
ZS named a Leader in 2026 IDC MarketScape for Life Science R&D RWD and RWE
/PRNewswire/ -- ZS, a global management consulting and technology firm, has been named a Leader in the IDC MarketScape: Worldwide Life Science R&D...
UMass Amherst Launches Historic, Transformational $120 Million Future of Food Initiative | Institute for Applied Life Sciences
UMass Amherst is launching a $120 million effort to address real-world concerns as the global food system faces critical challenges related to climate change and sustainability, food safety and a growing population expected to reach 10 billion people by 2050. The initiative will include a new 36,000 square foot research facility, a multidisciplinary collaborative research center, an endowed chair in food science and three endowed faculty positions who will examine crucial questions about the future of our global food system.
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health to Deliver Oral Comments at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs
Sarit Hashkes, President of Filament Health Corp., will provide oral remarks at the United States Food and Drug Administration public hearing "Considerations for Potential Future Therapeutic Use of Psychedelic Drugs", being held later today, September 14, 2026Toronto, Ontario--(Newsfile Corp. - September 14, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company"), an Ontario-based organization advancing innovation and research within the legal...
The new CEO of the R.I. Life Science Hub looks to the future
“Rhode Island has done this many times,” said Bob Cormier. “We’ve reinvented ourselves with the defense industry, with the Jewelry District, and I do think life sciences is the next part for us.”
James Hamrick Highlights Caris Life Sciences and Precision Oncology Alliance Research at WCLC26
James Hamrick Highlights Caris Life Sciences and Precision Oncology Alliance Research at WCLC26 / cancer, Caris Life Sciences, Caris Precision Oncology
Life Sciences Companies Present Live at the September 17 Virtual Investor Forum
Live Presentations and Q&A Across Oncology, Fibrosis, Drug Delivery, Antibiotics, Cannabinoid Therapeutics, and Respiratory Imaging A Global Lineup Presents Live Online: 30-Minute Sessions, Audience Q&A, Replays On Demand NEW YORK, NY - Sept...
Life Science Core Day to connect Cornell’s facility resources with researchers
Life Science Core Day, taking place Sept. 22, offers Cornell researchers a chance to explore an extraordinary range of specialized life science core facilities, technologies, and expertise available to them from across campus in one place.
Anthropic Signs 24,000-Square-Foot Lease in Cambridge, Drawn by Proximity to Life Science Research
Anthropic Signs 24,000-Square-Foot Lease in Cambridge, Drawn by Proximity to Life Science Research
Bristol life sciences manufacturer delays plant closure, final layoffs until year-end
IDEX Health has delayed the final closure of its Bristol facility and layoffs of up to 15 remaining employees until Dec. 31.
Uniting sequence and structure to map the protein universe across billions of years of evolution
An international team of researchers, including those at the Earth-Life Science Institute (ELSI) at the Institute of Science Tokyo, has developed a protein language model that brings together two fundamental ...
5 things to know in life sciences: Week of Sept. 7, 2026
Each week we highlight five things affecting the life sciences industry. Here’s the latest.
Pease Tradeport continues as NH economic engine
New report cites Tradeport’s ‘uniquely important role in New Hampshire’s economic architecture’ as executive director looks toward ‘retooling’ for life science users
Is Janus Henderson Global Life Science T (JAGLX) a Strong Mutual Fund Pick Right Now?
Mutual Fund Report for JAGLX
2025-26 Record Fundraising Year for Life Sciences at UC Davis
The University of California, Davis, raised more than $676 million in philanthropic support during fiscal year 2025–26, more than doubling the university's previous giving record and marking the strongest fundraising year in its history.Donors’ unprecedented level of investment in UC Davis will expand opportunities for students, strengthen faculty excellence, accelerate discoveries that improve lives, and support new facilities and programs that elevate the university’s impact across California and beyond.
Diego Martinez joins Texas A&M Department of Poultry Science
Diego A. Martinez, Ph.D., joined the Texas A&M Department of Poultry Science in the College of Agriculture and Life Sciences as an assistant professor of poultry nutrition on August 1.
Clearsight Advises Ambit in its Acquisition by Danforth Health
Clearsight Advisors, Inc. ("Clearsight") is pleased to announce a successful transaction in its Healthcare and Life Sciences Services practice. Clearsight served as the exclusive sell-side advisor to Ambit RD, Inc. (the "Company" or "Ambit") on its acquisition by Danforth Health, Inc. ("Danforth"), a portfolio company of Avesi Partners ("Avesi").
Luma locks down 15-year, $410M fund for life science investments
Luma Group today announced the final close of its inaugural life sciences venture capital fund, totaling $410 million. The New York-based investment firm has had a grip on life sciences since its founding in 2023. The funds unveiled today, dubbed LumaBio Fund I, include investments that have already been made into more than 10 biotechs. They include the likes of eye disease-focused Character Biosciences, rebranded Belgian biotech Coultreon Biopharma and cellular rejuvenation company Altos Labs. The fund saw early success when one of the companies it co-founded, called Vaccine Company, was picked up by Eli Lilly earlier this year for up to $1.55 billion. The acquisition of the in vivo nanoparticle technology-focused biotech formed part of a trio of vaccine buys for the Big Pharma, which has itself been on a prolonged spending spree in 2026. Luma's fund is structured as a 15-year investment with plans to support groundbreaking science and support companies through key milestones from discovery to commercialization, Luma explained in the release. "We founded Luma Group on the belief that extraordinary science, supported by patient, long-term capital, has the power to improve millions of lives," Joshua Fink, founder and managing member of Luma Group, said in the release. "This fund represents more than capital—it is a commitment to partnering with extraordinary innovators as they translate visionary science into life-changing medicines."
Cleveland Clinic, RIKEN and IBM Team Advance to Finals for 2026 ACM Gordon Bell Prize
Joint research team modeled a 12,635-atom protein, the largest-known to be simulated using quantum computers. Breakthrough was achieved through quantum and classical methods working together, expanding quantum-centric supercomputing’s potential in life sciences research.
What Will Life Science Orgs Do When The AI Bill Comes Through?
AI is transforming clinical development, but what happens when usage costs spike? Jon Newton explains how to govern it before the bill lands.
Bentley Awarded $235,000 to Strengthen Life Sciences Talent Pipeline
Bentley University will use $235,000 grant to prepare students for business roles in life sciences to meet Massachusetts workforce need.
SC's Emerging Biotech Industry Receives National Recognition
Genetic Engineering & Biotechnology News (GEN) recently named the Palmetto State among its “Regional and State Clusters to Watch” in its first-ever Next 10 U.S. Biopharma Clusters report, highlighting emerging life sciences ecosystems beyond...
Osaka has the science. Now it needs the business
Osaka is striving to turn world-class life sciences research into a global healthcare industry - testing whether Japan's pharma and biotech sector can finally scale internationally.
Osaka has the science. Now it needs the business
Osaka is striving to turn world-class life sciences research into a global healthcare industry - testing whether Japan's pharma and biotech sector can finally scale internationally.
Osaka has the science. Now it needs the business
Osaka is striving to turn world-class life sciences research into a global healthcare industry - testing whether Japan's pharma and biotech sector can finally scale internationally.
Osaka has the science. Now it needs the business
Osaka is striving to turn world-class life sciences research into a global healthcare industry - testing whether Japan's pharma and biotech sector can finally scale internationally.
How Burnham’s Britain can gain the edge in life sciences
Our country has historically been at the forefront of innovation. We need to bw flexible to fend off competition
MCC receives funding to support life sciences education, workforce development
In July, the Healey-Driscoll administration and the Massachusetts Life Sciences Center announced $12.3 million in funding through four tracks of the MLSC’s Education and Workforce Development Grant Program. Middlesex Community College r…